Short-Acting B2 Agonists Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on short-acting b2 agonists market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for short-acting b2 agonists ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The short-acting b2 agonists market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Type: Albuterol; Levalbuterol; Metaproterenol; Other Types
2) By Indication: Asthama; Chronic Obstructive Pulmonary Disease (COPD); Exercise-Induced Bronchospasm
3) By Administration Route: Inhalation; Oral; Injection
4) By End User: Hospitals; Clinics; Home Healthcare Settings
Subsegments:
1) By Albuterol: Inhalers; Nebulizers; Tablets; Syrups
2) By Levalbuterol: Inhalers; Nebulizers; Oral Solutions
3) By Metaproterenol: Inhalers; Syrups
4) By Other Types: Terbutaline; Pirbuterol; Salbutamol
Companies Mentioned: AstraZeneca plc; Novartis AG; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.; Apotex Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
- 1. Executive Summary
- 2. Short-Acting B2 Agonists Market Characteristics
- 3. Short-Acting B2 Agonists Market Trends And Strategies
- 4. Short-Acting B2 Agonists Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 5. Global Short-Acting B2 Agonists Growth Analysis And Strategic Analysis Framework
- 5.1. Global Short-Acting B2 Agonists PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Short-Acting B2 Agonists Market Growth Rate Analysis
- 5.4. Global Short-Acting B2 Agonists Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Short-Acting B2 Agonists Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Short-Acting B2 Agonists Total Addressable Market (TAM)
- 6. Short-Acting B2 Agonists Market Segmentation
- 6.1. Global Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Albuterol
- Levalbuterol
- Metaproterenol
- Other Types
- 6.2. Global Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Asthama
- Chronic Obstructive Pulmonary Disease (COPD)
- Exercise-Induced Bronchospasm
- 6.3. Global Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inhalation
- Oral
- Injeaction
- 6.4. Global Short-Acting B2 Agonists Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Home Healthcare Settings
- 6.5. Global Short-Acting B2 Agonists Market, Sub-Segmentation Of Albuterol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inhalers
- Nebulizers
- Tablets
- Syrups
- 6.6. Global Short-Acting B2 Agonists Market, Sub-Segmentation Of Levalbuterol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inhalers
- Nebulizers
- Oral Solutions
- 6.7. Global Short-Acting B2 Agonists Market, Sub-Segmentation Of Metaproterenol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inhalers
- Syrups
- 6.8. Global Short-Acting B2 Agonists Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Terbutaline
- Pirbuterol
- Salbutamol
- 7. Short-Acting B2 Agonists Market Regional And Country Analysis
- 7.1. Global Short-Acting B2 Agonists Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Short-Acting B2 Agonists Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Short-Acting B2 Agonists Market
- 8.1. Asia-Pacific Short-Acting B2 Agonists Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Short-Acting B2 Agonists Market
- 9.1. China Short-Acting B2 Agonists Market Overview
- 9.2. China Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Short-Acting B2 Agonists Market
- 10.1. India Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Short-Acting B2 Agonists Market
- 11.1. Japan Short-Acting B2 Agonists Market Overview
- 11.2. Japan Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Short-Acting B2 Agonists Market
- 12.1. Australia Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Short-Acting B2 Agonists Market
- 13.1. Indonesia Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Short-Acting B2 Agonists Market
- 14.1. South Korea Short-Acting B2 Agonists Market Overview
- 14.2. South Korea Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Short-Acting B2 Agonists Market
- 15.1. Western Europe Short-Acting B2 Agonists Market Overview
- 15.2. Western Europe Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Short-Acting B2 Agonists Market
- 16.1. UK Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Short-Acting B2 Agonists Market
- 17.1. Germany Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Short-Acting B2 Agonists Market
- 18.1. France Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Short-Acting B2 Agonists Market
- 19.1. Italy Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Short-Acting B2 Agonists Market
- 20.1. Spain Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Short-Acting B2 Agonists Market
- 21.1. Eastern Europe Short-Acting B2 Agonists Market Overview
- 21.2. Eastern Europe Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Short-Acting B2 Agonists Market
- 22.1. Russia Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Short-Acting B2 Agonists Market
- 23.1. North America Short-Acting B2 Agonists Market Overview
- 23.2. North America Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Short-Acting B2 Agonists Market
- 24.1. USA Short-Acting B2 Agonists Market Overview
- 24.2. USA Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Short-Acting B2 Agonists Market
- 25.1. Canada Short-Acting B2 Agonists Market Overview
- 25.2. Canada Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Short-Acting B2 Agonists Market
- 26.1. South America Short-Acting B2 Agonists Market Overview
- 26.2. South America Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Short-Acting B2 Agonists Market
- 27.1. Brazil Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Short-Acting B2 Agonists Market
- 28.1. Middle East Short-Acting B2 Agonists Market Overview
- 28.2. Middle East Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Short-Acting B2 Agonists Market
- 29.1. Africa Short-Acting B2 Agonists Market Overview
- 29.2. Africa Short-Acting B2 Agonists Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Short-Acting B2 Agonists Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Short-Acting B2 Agonists Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Short-Acting B2 Agonists Market Competitive Landscape And Company Profiles
- 30.1. Short-Acting B2 Agonists Market Competitive Landscape
- 30.2. Short-Acting B2 Agonists Market Company Profiles
- 30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Short-Acting B2 Agonists Market Other Major And Innovative Companies
- 31.1. Perrigo Company plc
- 31.2. Aurobindo Pharma Ltd.
- 31.3. Chiesi Farmaceutici S.p.A.
- 31.4. Cipla Limited
- 31.5. Hikma Pharmaceuticals PLC
- 31.6. Amneal Pharmaceuticals Inc.
- 31.7. Lupin Limited
- 31.8. Orion Corporation
- 31.9. Beximco Pharmaceuticals Ltd.
- 31.10. Micro Labs Limited
- 31.11. Neuland Laboratories Limited
- 31.12. Vectura Group plc
- 31.13. Nephron Pharmaceuticals Corporation
- 31.14. AdvaCare Pharma USA LLC
- 31.15. Midas Care Pharmaceuticals Pvt Ltd.
- 32. Global Short-Acting B2 Agonists Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Short-Acting B2 Agonists Market
- 34. Recent Developments In The Short-Acting B2 Agonists Market
- 35. Short-Acting B2 Agonists Market High Potential Countries, Segments and Strategies
- 35.1 Short-Acting B2 Agonists Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Short-Acting B2 Agonists Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Short-Acting B2 Agonists Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook